Atrandi
Atrandi Biosciences
Lithuania · Founded 2016 · $25.0M raised
- Founded
- 2016
- Business Model
- B2B
- Website
- atrandi.com
- Total Funding
- $25.0M
- Last Round
- $25.0M SeedFeb 2025
- Rounds
- 2
About
Single-cell analysis biotech providing droplet microfluidics tools and comprehensive toolkit for biological research.
Summary
Atrandi is a Biotech company based in Lithuania, founded in 2016. It has raised $25.0M in total across 2 rounds, most recently a $25.0M Seed round in Feb 2025. Investors include Practica Capital, Lux Capital and Vsquared Ventures.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...